Tigecycline resistance among carbapenem-resistant Klebsiella Pneumoniae: Clinical characteristics and expression levels of efflux pump genes

PLoS ONE

Volumn 12, Issue 4, 2017, Pages

  Chiu, Sheng Kang ^a,b   Chan, Ming Chin ^a   Huang, Li Yueh ^c   Lin, Yi Tsung ^d   Lin, Jung Chung ^a   Lu, Po Liang ^e   Siu, L Kristopher ^a,c,f   Chang, Feng Yee ^a   Yeh, Kuo Ming ^a  

^a TRI SERVICE GENERAL HOSPITAL   (Taiwan)

^b NATIONAL DEFENSE MEDICAL CENTER   (Taiwan)

^c NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

^d NATIONAL YANG MING UNIVERSITY   (Taiwan)

^e KAOHSIUNG MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^f CHINA MEDICAL UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

COLISTIN; TIGECYCLINE; ANTIINFECTIVE AGENT; CARBAPENEM DERIVATIVE; MINOCYCLINE;

ACRB GENE; AGED; ANTIBIOTIC RESISTANCE; ARTICLE; BACTEREMIA; BACTERIAL GENE; BACTERIUM ISOLATE; BILIARY TRACT INFECTION; CARBAPENEM RESISTANT ENTEROBACTERIACEAE; CARBAPENEM RESISTANT KLEBSIELLA PNEUMONIAE; CLINICAL ARTICLE; CONTROLLED STUDY; EFFLUX PUMP GENE; FEMALE; GENE EXPRESSION; GENE IDENTIFICATION; GENE OVEREXPRESSION; HUMAN; KLEBSIELLA PNEUMONIAE INFECTION; MALE; MORTALITY RATE; MULTILOCUS SEQUENCE TYPING; NONHUMAN; OQXB GENE; PERITONITIS; PNEUMONIA; PULSED FIELD GEL ELECTROPHORESIS; REAL TIME POLYMERASE CHAIN REACTION; URINARY TRACT INFECTION; ANALOGS AND DERIVATIVES; DRUG EFFECTS; GENETICS; KLEBSIELLA INFECTIONS; KLEBSIELLA PNEUMONIAE; MICROBIOLOGY; MIDDLE AGED; TRANSPORT AT THE CELLULAR LEVEL; URINARY TRACT INFECTIONS; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; BIOLOGICAL TRANSPORT; CARBAPENEMS; DRUG RESISTANCE, BACTERIAL; FEMALE; GENES, BACTERIAL; HUMANS; KLEBSIELLA INFECTIONS; KLEBSIELLA PNEUMONIAE; MALE; MIDDLE AGED; MINOCYCLINE; REAL-TIME POLYMERASE CHAIN REACTION; URINARY TRACT INFECTIONS;

EID: 85017158834     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0175140     Document Type: Article

References (38)

1. Siu LK, Yeh KM, Lin JC, Fung CP, Chang FY. Klebsiella pneumoniae liver abscess: a new invasive syndrome. The Lancet Infectious diseases. 2012; 12(11): 881-7. https://doi.org/10.1016/S1473-3099(12)70205-0 PMID: 23099082
2. Nordmann P, Cuzon G, Naas T. The real threat of Klebsiella pneumoniae carbapenemase-producing bacteria. The Lancet Infectious diseases. 2009; 9(4): 228-36. Epub 2009/03/28. https://doi.org/10.1016/S1473-3099(09)70054-4 PMID: 19324295
3. Neuner EA, Yeh JY, Hall GS, Sekeres J, Endimiani A, Bonomo RA, et al. Treatment and outcomes in carbapenem-resistant Klebsiella pneumoniae bloodstream infections. Diagn Microbiol Infect Dis. 2011; 69(4): 357-62. Epub 2011/03/15. PubMed Central PMCID: PMC3058153. https://doi.org/10.1016/j.diagmicrobio.2010.10.013 PMID: 21396529
4. Lee CR, Lee JH, Park KS, Kim YB, Jeong BC, Lee SH. Global Dissemination of Carbapenemase-Producing Klebsiella pneumoniae: Epidemiology, Genetic Context, Treatment Options, and Detection Methods. Frontiers in microbiology. 2016; 7: 895. PubMed Central PMCID: PMC4904035. https://doi.org/10.3389/fmicb.2016.00895 PMID: 27379038
5. Sheng ZK, Wang W, Guo Q, Xu X, Wang M, Yang Y, et al. Emergence of tigecycline- and carbapenem-nonsusceptible Klebsiella pneumoniae ST11 clone in patients without exposure to tigecycline. Journal of microbiology, immunology, and infection. 2016; 49(6): 962-8. https://doi.org/10.1016/j.jmii.2015.10.014 PMID: 26692183
6. van Duin D, Cober ED, Richter SS, Perez F, Cline M, Kaye KS, et al. Tigecycline therapy for carbapenem-resistant Klebsiella pneumoniae (CRKP) bacteriuria leads to tigecycline resistance. Clinical microbiology and infection: the official publication of the European Society of Clinical Microbiology and Infectious Diseases. 2014; 20(12): O1117-20. PubMed Central PMCID: PMC4265572.
7. van Duin D, Cober E, Richter SS, Perez F, Kalayjian RC, Salata RA, et al. Residence in Skilled Nursing Facilities Is Associated with Tigecycline Nonsusceptibility in Carbapenem-Resistant Klebsiella pneumoniae. Infect Control Hosp Epidemiol. 2015; 36(8): 942-8. PubMed Central PMCID: PMCPMC4642723. https://doi.org/10.1017/ice.2015.118 PMID: 25990806
8. Chiu SK, Wu TL, Chuang YC, Lin JC, Fung CP, Lu PL, et al. National surveillance study on carbapenem non-susceptible Klebsiella pneumoniae in Taiwan: the emergence and rapid dissemination of KPC-2 carbapenemase. PloS one. 2013; 8(7): e69428. PubMed Central PMCID: PMC3722148. https://doi.org/10.1371/journal.pone.0069428 PMID: 23894478
9. Sheng ZK, Hu F, Wang W, Guo Q, Chen Z, Xu X, et al. Mechanisms of tigecycline resistance among Klebsiella pneumoniae clinical isolates. Antimicrobial agents and chemotherapy. 2014; 58(11): 6982-5. PubMed Central PMCID: PMCPMC4249433. https://doi.org/10.1128/AAC.03808-14 PMID: 25182649
10. Jeong SH, Kim HS, Kim JS, Shin DH, Kim HS, Park MJ, et al. Prevalence and Molecular Characteristics of Carbapenemase-Producing Enterobacteriaceae From Five Hospitals in Korea. Annals of laboratory medicine. 2016; 36(6): 529-35. PubMed Central PMCID: PMC5011105. https://doi.org/10.3343/alm.2016.36.6.529 PMID: 27578505
11. Sun Y, Cai Y, Liu X, Bai N, Liang B, Wang R. The emergence of clinical resistance to tigecycline. International journal of antimicrobial agents. 2013; 41(2): 110-6. https://doi.org/10.1016/j.ijantimicag.2012.09.005 PMID: 23127485
12. Pournaras S, Koumaki V, Spanakis N, Gennimata V, Tsakris A. Current perspectives on tigecycline resistance in Enterobacteriaceae: susceptibility testing issues and mechanisms of resistance. International journal of antimicrobial agents. 2016; 48(1): 11-8. https://doi.org/10.1016/j.ijantimicag.2016.04.017 PMID: 27256586
13. Bialek-Davenet S, Lavigne JP, Guyot K, Mayer N, Tournebize R, Brisse S, et al. Differential contribution of AcrAB and OqxAB efflux pumps to multidrug resistance and virulence in Klebsiella pneumoniae. The Journal of antimicrobial chemotherapy. 2015; 70(1): 81-8. https://doi.org/10.1093/jac/dku340 PMID: 25193085
14. Elkins CA, Nikaido H. Substrate specificity of the RND-type multidrug efflux pumps AcrB and AcrD of Escherichia coli is determined predominantly by two large periplasmic loops. Journal of bacteriology. 2002; 184(23): 6490-8. PubMed Central PMCID: PMC135441. https://doi.org/10.1128/JB.184.23.6490-6498.2002 PMID: 12426336
15. Kim HB, Wang M, Park CH, Kim EC, Jacoby GA, Hooper DC. oqxAB encoding a multidrug efflux pump in human clinical isolates of Enterobacteriaceae. Antimicrobial agents and chemotherapy. 2009; 53 (8): 3582-4. PubMed Central PMCID: PMC2715617. https://doi.org/10.1128/AAC.01574-08 PMID: 19528276
16. Breakpoint tables for interpretation of MICs and zone diameters [Internet]. European Committee on Antimicrobial Susceptibility Testing. 2016. Available from: http://www.eucast.org/fileadmin/src/media/PDFs/EUCAST-files/Breakpoint-tables/v-6.0-Breakpoint-table.pdf. Accessed 2016 Dec 12.
17. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing; 25th informational supplement; 100-S25 2015.
18. Zarkotou O, Pournaras S, Tselioti P, Dragoumanos V, Pitiriga V, Ranellou K, et al. Predictors of mortality in patients with bloodstream infections caused by KPC-producing Klebsiella pneumoniae and impact of appropriate antimicrobial treatment. Clinical microbiology and infection: the official publication of the European Society of Clinical Microbiology and Infectious Diseases. 2011; 17(12): 1798-803.
19. Queenan AM, Bush K. Carbapenemases: the versatile beta-lactamases. Clinical microbiology reviews. 2007; 20(3): 440-58, table of contents. PubMed Central PMCID: PMC1932750. https://doi.org/10.1128/CMR.00001-07 PMID: 17630334
20. D'Agata EM, Gerrits MM, Tang YW, Samore M, Kusters JG. Comparison of pulsed-field gel electrophoresis and amplified fragment-length polymorphism for epidemiological investigations of common nosocomial pathogens. Infect Control Hosp Epidemiol. 2001; 22(9): 550-4. Epub 2001/12/06. https://doi.org/10.1086/501950 PMID: 11732783
21. Tenover FC, Arbeit RD, Goering RV, Mickelsen PA, Murray BE, Persing DH, et al. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. Journal of clinical microbiology. 1995; 33(9): 2233-9. Epub 1995/09/01. PubMed Central PMCID: PMC228385. PMID: 7494007
22. Diancourt L, Passet V, Verhoef J, Grimont PA, Brisse S. Multilocus sequence typing of Klebsiella pneumoniae nosocomial isolates. Journal of clinical microbiology. 2005; 43(8): 4178-82. Epub 2005/08/06. PubMed Central PMCID: PMC1233940. https://doi.org/10.1128/JCM.43.8.4178-4182.2005 PMID: 16081970
23. Nielsen LE, Snesrud EC, Onmus-Leone F, Kwak YI, Aviles R, Steele ED, et al. IS5 element integration, a novel mechanism for rapid in vivo emergence of tigecycline nonsusceptibility in Klebsiella pneumoniae. Antimicrobial agents and chemotherapy. 2014; 58(10): 6151-6. PubMed Central PMCID: PMC4187979. https://doi.org/10.1128/AAC.03053-14 PMID: 25092708
24. Palacios-Baena ZR, Oteo J, Conejo C, Larrosa MN, Bou G, Fernandez-Martinez M, et al. Comprehensive clinical and epidemiological assessment of colonisation and infection due to carbapenemase-producing Enterobacteriaceae in Spain. The Journal of infection. 2016; 72(2): 152-60. https://doi.org/10.1016/j.jinf.2015.10.008 PMID: 26546855
25. Nigo M, Cevallos CS, Woods K, Flores VM, Francis G, Perlman DC, et al. Nested case-control study of the emergence of tigecycline resistance in multidrug-resistant Klebsiella pneumoniae. Antimicrobial agents and chemotherapy. 2013; 57(11): 5743-6. PubMed Central PMCID: PMCPMC3811295. https://doi.org/10.1128/AAC.00827-13 PMID: 23979745
26. Roy S, Datta S, Viswanathan R, Singh AK, Basu S. Tigecycline susceptibility in Klebsiella pneumoniae and Escherichia coli causing neonatal septicaemia (2007-10) and role of an efflux pump in tigecycline non-susceptibility. The Journal of antimicrobial chemotherapy. 2013; 68(5): 1036-42. https://doi.org/10.1093/jac/dks535 PMID: 23335112
27. Tumbarello M, Viale P, Viscoli C, Trecarichi EM, Tumietto F, Marchese A, et al. Predictors of mortality in bloodstream infections caused by Klebsiella pneumoniae carbapenemase-producing K. pneumoniae: importance of combination therapy. Clinical infectious diseases: an official publication of the Infectious Diseases Society of America. 2012; 55(7): 943-50.
28. Wu PF, Chuang C, Su CF, Lin YT, Chan YJ, Wang FD, et al. High minimum inhibitory concentration of imipenem as a predictor of fatal outcome in patients with carbapenem non-susceptible Klebsiella pneumoniae. Sci Rep. 2016; 6: 32665. PubMed Central PMCID: PMC 5009345. https://doi.org/10.1038/srep32665 PMID: 27585787
29. Qi Y, Wei Z, Ji S, Du X, Shen P, Yu Y. ST11, the dominant clone of KPC-producing Klebsiella pneumoniae in China. The Journal of antimicrobial chemotherapy. 2011; 66(2): 307-12. https://doi.org/10.1093/jac/dkq431 PMID: 21131324
30. Balm MN, Ngan G, Jureen R, Lin RT, Teo J. Molecular characterization of newly emerged blaKPC-2-producing Klebsiella pneumoniae in Singapore. Journal of clinical microbiology. 2012; 50(2): 475-6. PubMed Central PMCID: PMC3264177. https://doi.org/10.1128/JCM.05914-11 PMID: 22116160
31. Rosenblum R, Khan E, Gonzalez G, Hasan R, Schneiders T. Genetic regulation of the ramA locus and its expression in clinical isolates of Klebsiella pneumoniae. International journal of antimicrobial agents. 2011; 38(1): 39-45. PubMed Central PMCID: PMC3117140. https://doi.org/10.1016/j.ijantimicag.2011.02.012 PMID: 21514798
32. Juan CH, Huang YW, Lin YT, Yang TC, Wang F-D. Risk Factors, Outcomes, and Mechanisms of Tige-cycline-Nonsusceptible Klebsiella pneumoniae Bacteremia. Antimicrobial agents and chemotherapy. 2016; 60: 7357-63. https://doi.org/10.1128/AAC.01503-16 PMID: 27697759
33. Hentschke M, Wolters M, Sobottka I, Rohde H, Aepfelbacher M. ramR mutations in clinical isolates of Klebsiella pneumoniae with reduced susceptibility to tigecycline. Antimicrobial agents and chemotherapy. 2010; 54(6): 2720-3. PubMed Central PMCID: PMC2876394. https://doi.org/10.1128/AAC.00085-10 PMID: 20350947
34. Villa L, Feudi C, Fortini D, Garcia-Fernandez A, Carattoli A. Genomics of KPC-producing Klebsiella pneumoniae sequence type 512 clone highlights the role of RamR and ribosomal S10 protein mutations in conferring tigecycline resistance. Antimicrobial agents and chemotherapy. 2014; 58(3): 1707-12. PubMed Central PMCID: PMC3957836. https://doi.org/10.1128/AAC.01803-13 PMID: 24379204
35. Veleba M, Higgins PG, Gonzalez G, Seifert H, Schneiders T. Characterization of RarA, a novel AraC family multidrug resistance regulator in Klebsiella pneumoniae. Antimicrobial agents and chemotherapy. 2012; 56(8): 4450-8. PubMed Central PMCID: PMC3421627. https://doi.org/10.1128/AAC.00456-12 PMID: 22644028
36. De Majumdar S, Yu J, Fookes M, McAteer SP, Llobet E, Finn S, et al. Elucidation of the RamA regulon in Klebsiella pneumoniae reveals a role in LPS regulation. PLoS Pathog. 2015; 11(1): e1004627. PubMed Central PMCID: PMCPMC4310594. https://doi.org/10.1371/journal.ppat.1004627 PMID: 25633080
37. De Majumdar S, Veleba M, Finn S, Fanning S, Schneiders T. Elucidating the regulon of multidrug resistance regulator RarA in Klebsiella pneumoniae. Antimicrobial agents and chemotherapy. 2013; 57 (4): 1603-9. PubMed Central PMCID: PMCPMC3623357. https://doi.org/10.1128/AAC.01998-12 PMID: 23318802
38. Bratu S, Landman D, George A, Salvani J, Quale J. Correlation of the expression of acrB and the regulatory genes marA, soxS and ramA with antimicrobial resistance in clinical isolates of Klebsiella pneumoniae endemic to New York City. The Journal of antimicrobial chemotherapy. 2009; 64(2): 278-83. PubMed Central PMCID: PMC2707265. https://doi.org/10.1093/jac/dkp186 PMID: 19457933